» Articles » PMID: 32701911

COVID-19 Mortality Rate in Nine High-income Metropolitan Regions

Overview
Journal Acta Biomed
Specialty General Medicine
Date 2020 Jul 24
PMID 32701911
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

We analyzed the spread of the COVID-19 epidemic in 9 metropolitan regions of the world with similar socio-demographic characteristics, daytime commuting population and business activities: the New York State, Bruxelles-Capital, the Community of Madrid, Catalonia, the Île-de-France Region, the Greater London county, Stockholms län, Hovedstaden (Copenhagen) and the Lombardy Region. The Lombardy region reported the highest COVID-19 crude mortality rate (141.0 x 100,000) 70-days after the onset of the epidemic, followed by the Community of Madrid (132.8 x 100,000) New York State (120.7 x 100,000). The large variation in COVID-19 mortality and case-fatality rates for COVID-19 in different age strata suggested a more accurate analysis and interpretation of the epidemic dynamics after standardization of the rates by age. The share of elder populations (>70 years) over total population varies widely in the considered study settings, ranging from 6.9% in Catalonia to 17.0% in Lombardy. When taking age distribution into consideration the highest standardized mortality rate was observed in the State of New York (257.9 x 100,000); with figures in most of the European regions concentrated between 123.3 x 100,000 in Greater London and 177.7 x 100,000 in Bruxelles-Capital, lower in French and Danish regions. We also report and critical appraise, when available, COVID-19 mortality figures in capital cities, nursing homes, as well as excess mortality at country level. Our data raise awareness on the need for a more in-depth epidemiological analysis of the current COVID-19 public health emergency that further explores COVID-19 mortality determinants associated with health services delivery, community-level healthcare, testing approaches and characteristics of surveillance systems, including classification of COVID-19 deaths.

Citing Articles

Characteristics of Home and Neighborhood Built Environments During COVID-19 for Older Adults in the United States and Italy.

Anderson D, DeCaro R, Chadalavada M, Marin A, Di Crosta A, Ceccato I J Aging Environ. 2024; 2023:1-37.

PMID: 39055175 PMC: 11271746. DOI: 10.1080/26892618.2023.2269552.


Characteristics of Hospitalized COVID-19 Patients at Admission and Factors Associated with Clinical Severity in Low- and Middle-Income Countries: An Observational Study.

Abifadel M, Ahmmed K, Banu S, Camara I, Chowdhury F, Coulibaly D Am J Trop Med Hyg. 2024; 110(4):741-748.

PMID: 38412531 PMC: 10993839. DOI: 10.4269/ajtmh.23-0456.


COVID-19 infections, recoveries, and mortality: an ANOVA model of locations and administrative areas in Saudi Arabia.

Aldossari H, Salam A Front Public Health. 2024; 12:1281289.

PMID: 38299074 PMC: 10829572. DOI: 10.3389/fpubh.2024.1281289.


Digital Information Approach through Social Media among Gen Z and Millennials: The Global Scenario during the COVID-19 Pandemic.

Blandi L, Sabbatucci M, Dallagiacoma G, Alberti F, Bertuccio P, Odone A Vaccines (Basel). 2022; 10(11).

PMID: 36366331 PMC: 9696549. DOI: 10.3390/vaccines10111822.


The First 110,593 COVID-19 Patients Hospitalised in Lombardy: A Regionwide Analysis of Case Characteristics, Risk Factors and Clinical Outcomes.

Mauer N, Chiecca G, Carioli G, Gianfredi V, Iacoviello L, Bertagnolio S Int J Public Health. 2022; 67:1604427.

PMID: 35645700 PMC: 9131487. DOI: 10.3389/ijph.2022.1604427.


References
1.
Capolongo S, Rebecchi A, Buffoli M, Appolloni L, Signorelli C, Fara G . COVID-19 and Cities: from Urban Health strategies to the pandemic challenge. A Decalogue of Public Health opportunities. Acta Biomed. 2020; 91(2):13-22. PMC: 7569650. DOI: 10.23750/abm.v91i2.9615. View

2.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

3.
Castaldi S, Romano L, Pariani E, Garbelli C, Biganzoli E . COVID-19: the end of lockdown what next?. Acta Biomed. 2020; 91(2):236-238. PMC: 7569651. DOI: 10.23750/abm.v91i2.9605. View

4.
Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y . Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020; 146(1):110-118. PMC: 7152876. DOI: 10.1016/j.jaci.2020.04.006. View

5.
Wilder-Smith A, Chiew C, Lee V . Can we contain the COVID-19 outbreak with the same measures as for SARS?. Lancet Infect Dis. 2020; 20(5):e102-e107. PMC: 7102636. DOI: 10.1016/S1473-3099(20)30129-8. View